Provenance Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75.2K Buy
150
+4
+3% +$1.92K 0.01% 201
2026
Q1
$71.8K Hold
146
0.01% 182
2025
Q4
$84.6K Hold
146
0.01% 163
2025
Q3
$70.8K Hold
146
0.01% 192
2025
Q2
$59.2K Buy
146
+114
+356% +$47.7K 0.01% 200
2025
Q1
$15.9K Hold
32
﹤0.01% 297
2024
Q4
$16.6K Sell
32
-11
-26% -$6.05K ﹤0.01% 285
2024
Q3
$26.6K Sell
43
-13
-23% -$7.7K ﹤0.01% 273
2024
Q2
$31K Hold
56
﹤0.01% 234
2024
Q1
$32.5K Hold
56
﹤0.01% 244
2023
Q4
$29.7K Sell
56
-76
-58% -$36.8K ﹤0.01% 238
2023
Q3
$66.8K Buy
+132
New +$70.3K 0.01% 165

Other funds holding TMO

Provenance Wealth Advisors's TMO Position: Q2 2026 in Review

Provenance Wealth Advisors increased its Thermo Fisher Scientific (TMO) stake by 2.7% in Q2 2026, buying an estimated $1.92K and bringing the position to 150 shares worth $75.2K. The position accounts for 0.01% of the portfolio, ranked #201.

Provenance Wealth Advisors first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $84.6K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Provenance Wealth Advisors held 150 shares of Thermo Fisher Scientific worth $75.2K as of Q2 2026.
  • Provenance Wealth Advisors bought 4 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.92K.
  • Thermo Fisher Scientific made up 0.01% of Provenance Wealth Advisors's portfolio in Q2 2026, its #201 holding.
  • Provenance Wealth Advisors first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
  • Provenance Wealth Advisors's Thermo Fisher Scientific position peaked at $84.6K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Provenance Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.